PMID- 16412331 OWN - NLM STAT- MEDLINE DCOM- 20070914 LR - 20181203 IS - 0529-567X (Print) IS - 0529-567X (Linking) VI - 40 IP - 12 DP - 2005 Dec TI - [RNA interference silencing expression of survivin gene and reversing drug resistance of ovarian cancer cell line SKOV3/ADM]. PG - 836-9 AB - OBJECTIVE: To examine expression of survivin gene in ovarian epithelial carcinoma drug resistant cell line SKOV3/ADM and its parental cell line SKOV3, and induction of cells apoptosis and reversal of drug resistance in SKOV3/ADM after RNA interference (RNAi) silencing survivin gene. METHODS: The transcription of survivin gene in cells was detected by semi-quantitative RT-PCR, the protein expression level of survivin gene was analyzed by immunofluorescence staining. SKOV3/ADM cells were treated with pshRNA-survivin and paclitaxel (Taxol), and acridine orange (AO)/ethidium bromide (EB) staining was performed to evaluate the apoptosis of cells. RESULTS: Survivin gene mRNA expressed by 99.1% and 75.3% respectively in cell lines SKOV3/ADM and SKOV3, while fluorescent cells were 59 +/- 5 and 42 +/- 3 (P < 0.05). After the introduction of pshRNA-survivin into SKOV3/ADM, mRNA transcription level of survivin gene decreased distinctly from 99.1% to 7.9%. The apoptotic cells of control group detected by AO/EB staining was 3.6 +/- 0.6, of Taxol group 10.2 +/- 1.0, of RNAi group 48.5 +/- 4.9, of RNAi + Taxol group 71.5 +/- 6.8. Apoptosis ratio between RNAi + Taxol group and RNAi group had significant difference (P < 0.05), and that between RNAi + Taxol group and Taxol group also had significant difference (P < 0.05). CONCLUSIONS: Both survivin gene mRNA and its protein are over-expressed in ovarian epithelial carcinoma cell lines SKOV3 and SKOV3/ADM, the level of survivin gene expressed in SKOV3/ADM is obviously different compared with that in its parental cell line SKOV3. RNA interference targeted against specific sequences of survivin in SKOV3/ADM cell could significantly reduce the level of survivin mRNA transcripts and protein, effectively induce the cells apoptosis and restore the sensitivity of cell to conventional chemotherapeutic agents Taxol. FAU - Deng, Kai-xian AU - Deng KX AD - Department of Obstetrics and Gynecology, Second Affiliated Hospital, Chongqing University of Medical Science, Chongqing 400010, China. FAU - Zhong, Ling AU - Zhong L FAU - Jiang, Mei-xian AU - Jiang MX FAU - Wang, Ping-ling AU - Wang PL FAU - Chen, Ying AU - Chen Y LA - chi PT - Journal Article PL - China TA - Zhonghua Fu Chan Ke Za Zhi JT - Zhonghua fu chan ke za zhi JID - 16210370R RN - 0 (Antineoplastic Agents) RN - 0 (BIRC5 protein, human) RN - 0 (Inhibitor of Apoptosis Proteins) RN - 0 (Microtubule-Associated Proteins) RN - 0 (Neoplasm Proteins) RN - 0 (RNA, Messenger) RN - 0 (RNA, Small Interfering) RN - 0 (Survivin) SB - IM MH - Animals MH - Antineoplastic Agents/pharmacology MH - Apoptosis MH - Cell Line, Tumor MH - Drug Resistance, Neoplasm/*genetics MH - Female MH - *Gene Silencing MH - Humans MH - Inhibitor of Apoptosis Proteins MH - Microtubule-Associated Proteins/biosynthesis/*genetics MH - Neoplasm Proteins/*genetics MH - Ovarian Neoplasms/genetics/*metabolism MH - RNA Interference MH - RNA, Messenger/biosynthesis/genetics MH - *RNA, Small Interfering MH - Reverse Transcriptase Polymerase Chain Reaction MH - Survivin MH - Transfection EDAT- 2006/01/18 09:00 MHDA- 2007/09/15 09:00 CRDT- 2006/01/18 09:00 PHST- 2006/01/18 09:00 [pubmed] PHST- 2007/09/15 09:00 [medline] PHST- 2006/01/18 09:00 [entrez] PST - ppublish SO - Zhonghua Fu Chan Ke Za Zhi. 2005 Dec;40(12):836-9.